TuHURA Biosciences, Inc./NV · CIK 1498382
TuHURA Biosciences, Inc./NV
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
2
Amendments
0
Activity
Jun 13, 2025
through Nov 10, 2025
through Nov 10, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jun 13, 2025 · D | Nov 10, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $12,612,120 | $3,000,000 | $-9,612,120 |
| Reported amount sold | $2,228,043 | $1,500,000 | $-728,043 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0000950123-25-006026 · Later SEC source: 0001498382-25-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $3,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $1,500,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0001498382-25-000004D · Nov 10, 2025 · BiotechnologyOffering: $3,000,000Sold: $1,500,000
Compared with 0000950123-25-006026:
- Reported offering amount: $12,612,120 → $3,000,000
- Reported amount sold: $2,228,043 → $1,500,000
-
0000950123-25-006026D · Jun 13, 2025 · BiotechnologyOffering: $12,612,120Sold: $2,228,043